Bristol Myers Squibb maintains a flexible ways of working framework that offers hybrid options for eligible positions, allowing employees in applicable roles to work remotely up to 50% of their scheduled time over a two-week period. Remote eligibility is role-specific, with site-essential operational and laboratory positions requiring on-site presence, while medical, clinical research, and field-based clinical roles permit remote or flexible arrangements.

Bristol Myers Squibb discovers, develops, manufactures, and commercializes biopharmaceutical prescription therapies. Its principal product lines include targeted treatments for oncology, hematology, immunology, cardiovascular conditions, and neuroscience. The company provides specialized medical scientific liaison support, clinical trial execution, patient assistance resources, and drug safety monitoring across its therapeutic portfolios globally.

Headquartered in Princeton, New Jersey, Bristol Myers Squibb operates globally with commercial, research, and manufacturing facilities across North America, Europe, Asia-Pacific, and Latin America. Its prescription medicines are distributed in more than 50 countries worldwide, supported by regional capability centers, biopharmaceutical research laboratories, and manufacturing plants.